Mr Mrs Miss Ms Dr Other

Dr
Vivien
Verbrugge

Partner & Patent Attorney

Rennes Office

Engineering

Telephone. +33672866728
Mobile. +33672866728
Email. [email protected]

Experience

Vivien’s wealth of experience as an in-house attorney, advising at Management and Board level within global companies in multiple jurisdictions, makes him well placed to advise in-house IP and Legal Counsel in relation to IP opportunities and threats for both SMEs and multinationals. Vivien regularly advises clients on portfolio creation, infringement avoidance and freedom to commercialise, portfolio enforcement and dispute resolution matters. Vivien has also advised on multi-jurisdiction portfolio acquisitions, secured successful outcomes in EPO oppositions and coordinated many IP litigations.

Qualifications

Patent Attorney

Europe
French


MPHYS

Master in Physics & engineer degree

LLM

University of Strasbourg

PHD

Physics, Optoectronics and Telecom

OTHER

Vlerick management program

Conferences: 2022

May 31st 2022

Innovation & IP Forum and Awards 2022

Attended

Event details

Related News

Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Basics of trade mark protection - National and European perspectives

HGF is pleased to invite you to our upcoming German speaking seminar on “Fundamentals of trade mark protection: National and European Perspectives” in Salzburg and Dresden. The seminar will cover …

Event details

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.